Edison, NJ, United States of America

Arasu Tamil

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Ptc Therapeutics, Inc.. Active years: 2021.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arasu Tamil: Innovator in Tetrahydro Beta-Carboline Synthesis

Introduction

Arasu Tamil is a notable inventor based in Edison, NJ (US). He has made significant contributions to the field of chemistry, particularly in the synthesis of complex organic compounds. His work has implications for various applications in pharmaceuticals and medicinal chemistry.

Latest Patents

Arasu Tamil holds a patent for "Processes for the preparation of substituted tetrahydro beta-carbolines." This patent outlines improved processes for synthesizing substituted tetrahydro beta-carboline derivatives. Specifically, it details methods useful for preparing (S)-4-chlorophenyl 6-chloro-1-(4-methoxyphenyl)-3,4-dihydro-1H-pyrido[3,4-b]indole-2(9H)-carboxylate. He has 1 patent to his name, showcasing his innovative approach to chemical synthesis.

Career Highlights

Arasu Tamil is currently employed at PTC Therapeutics, Inc., where he continues to advance his research in organic chemistry. His work at the company has allowed him to collaborate with other talented scientists and contribute to groundbreaking projects.

Collaborations

Some of his notable coworkers include Peter Seongwoo Hwang and Young-Choon Moon. Their collaborative efforts have further enhanced the research environment at PTC Therapeutics, Inc.

Conclusion

Arasu Tamil is a distinguished inventor whose work in the synthesis of tetrahydro beta-carbolines has the potential to impact the pharmaceutical industry significantly. His innovative processes and collaborations with esteemed colleagues highlight his commitment to advancing scientific knowledge.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…